| Rebecca Fieles, MD | |
|
1515 Village Dr, Cottage Grove, OR 97424-9700 | |
| (541) 767-5222 | |
| (541) 767-5230 |
| Full Name | Rebecca Fieles |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1515 Village Dr, Cottage Grove, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356960736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD214153 (Oregon) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Entity Name | Eugene Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831133677 PECOS PAC ID: 2264330448 Enrollment ID: O20031226000011 |
News Archive
Lung transplant patients who took part in a three-month structured exercise program when they were discharged from hospital improved their health-related quality of life and reduced their risk of cardiovascular problems.
Early reports have shown the COVID-19 pandemic has resulted in a decline in patients seeking outpatient medical care.
Data presented today suggest that 20 percent liquid formulation, Immune Globulin Subcutaneous (Human) (SCIg), or IgPro20 effectively protects patients with primary immunodeficiencies (PI) against infection. The 20 percent formulation, the highest Ig concentration currently available, was also shown to sustain serum IgG levels without causing unexpected rates of adverse events. The data were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in New Orleans, US.
Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.
Drug resistance is making many diseases increasingly difficult and sometimes impossible to treat, according to Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
› Verified 7 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902892391 PECOS PAC ID: 1254242357 Enrollment ID: O20040513000725 |
News Archive
Lung transplant patients who took part in a three-month structured exercise program when they were discharged from hospital improved their health-related quality of life and reduced their risk of cardiovascular problems.
Early reports have shown the COVID-19 pandemic has resulted in a decline in patients seeking outpatient medical care.
Data presented today suggest that 20 percent liquid formulation, Immune Globulin Subcutaneous (Human) (SCIg), or IgPro20 effectively protects patients with primary immunodeficiencies (PI) against infection. The 20 percent formulation, the highest Ig concentration currently available, was also shown to sustain serum IgG levels without causing unexpected rates of adverse events. The data were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in New Orleans, US.
Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.
Drug resistance is making many diseases increasingly difficult and sometimes impossible to treat, according to Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Fieles, MD 1 Cooper Plz, Camden, NJ 08103-1461 Ph: () - | Rebecca Fieles, MD 1515 Village Dr, Cottage Grove, OR 97424-9700 Ph: (541) 767-5222 |
News Archive
Lung transplant patients who took part in a three-month structured exercise program when they were discharged from hospital improved their health-related quality of life and reduced their risk of cardiovascular problems.
Early reports have shown the COVID-19 pandemic has resulted in a decline in patients seeking outpatient medical care.
Data presented today suggest that 20 percent liquid formulation, Immune Globulin Subcutaneous (Human) (SCIg), or IgPro20 effectively protects patients with primary immunodeficiencies (PI) against infection. The 20 percent formulation, the highest Ig concentration currently available, was also shown to sustain serum IgG levels without causing unexpected rates of adverse events. The data were presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in New Orleans, US.
Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.
Drug resistance is making many diseases increasingly difficult and sometimes impossible to treat, according to Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
› Verified 7 days ago
Annaleigh Boggess, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Village Dr, Cottage Grove, OR 97424 Phone: 541-767-5222 Fax: 541-767-5230 | |
Kimberly Cronin, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1515 Village Dr, Cottage Grove, OR 97424 Phone: 541-942-0511 Fax: 541-942-0353 | |
Dr. Kenneth Thomas Goodell, KEN GOODELL Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Village Dr, Emergency Department, Cottage Grove, OR 97424 Phone: 541-942-0511 | |
Daniel Kranitz, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Village Dr, Cottage Grove, OR 97424 Phone: 541-942-0511 Fax: 541-942-0353 | |
Un Sok Seo, M.D. UN Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 Village Dr, Cottage Grove, OR 97424 Phone: 541-942-0511 Fax: 541-942-0353 | |
Phillip Bonar, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1515 Village Dr, Cottage Grove, OR 97424 Phone: 541-767-5222 Fax: 541-767-5230 |